HAEK.DE

HAEMATO AG [HAEK.DE] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

HAEK.DE Stock Summary

In the News

HAEK.DE Financial details

Company Rating
-
Market Cap
111.5M
Income
9.97M
Revenue
515.3M
Book val./share
-
Cash/share
-
Dividend
1.2
Dividend %
4.62%
Employees
76
Optionable
No
Shortable
Yes
Earnings
29 May 2024
P/E
18.55
Forward P/E
-
PEG
3.44
P/S
1.07
P/B
0.91
P/C
-
P/FCF
13.78
Quick Ratio
1.57
Current Ratio
2.46
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
1.92
EPS next Y
-
EPS next Q
-
EPS this Y
25.6%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-10.93%
Revenue last 5Y
-1.97%
Revenue Q/Q
5.09%
EPS Q/Q
-68.79%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
4%
ROE
7%
ROC
0.03%
Gross Margin
7%
Oper. Margin
3%
Profit Margin
6%
Payout
78%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
17.4-28.0
52W High
-23.57%
52W Low
+25.88%
RSI
-
Rel Volume
0.3
Avg Volume
5.95K
Volume
1.79K
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
0.94%
-
-
-
-
Beta
1.294
-
-
Volatility
0.1%, 0.1%
Prev Close
0%
Price
21.4
Change
0%

HAEK.DE Financial Performance

HAEK.DE Dividend History

HAEK.DE Frequently Asked Questions

What is HAEMATO AG stock symbol ?

HAEMATO AG is a DE stock and trading under the symbol HAEK.DE

What is HAEMATO AG stock quote today ?

HAEMATO AG stock price is $21.4 today.

Is HAEMATO AG stock public?

Yes, HAEMATO AG is a publicly traded company.

Something similar

Top by Market Cap
EMBASSY.NS
BRK-B
AMZN
ABEA.DE
0YXG.L
Same Sector
NWBO
ORTINLAB.NS
TSVT
000538.SZ
ARTH
Check Those
AGFS
VBLT
DLCA
306200.KS
001219.SZ
Similar Market Cap
0784.HK
SPYR.DE
IQST
IOAC
BSMR

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 5.95K
  • Market Capitalization 111.5M
  • Employee 76
  • CEO Mr. Patrick Brenske
  • Headquarters Schönefeld,DE
  • IPO Date 2007-12-28
  • Website https://www.haemato.ag

HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European imported drugs and medical products; and manufactures and distributes its generic drugs. It provides pharmaceuticals in the areas of oncology, HIV, rheumatism, neurology, and cardiovascular diseases; and products for aesthetic medicine, as well as cosmetic products. The company also develops and markets medical devices and medical technology products for aesthetic surgery and cosmetic dermatology. It serves wholesalers and pharmacies, as well as doctors, clinics, and medical laboratories. HAEMATO AG was founded in 1993 and is based in Schönefeld, Germany.